HOPMAN MARK (Chief Commercial Officer) sold 35.3% of their position (30.78K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $619.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/17/2026ACC: 0002048497-26-000015
Officer· Chief Commercial Officer
Since Mar 2026
-30.78K
Net shares
Net seller
$619.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30.78K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−30.78K
Price / share
$20.13
Trade value
$619.64K
% of position
35.3%
9/16/2026
87.26K→56.48K
Total
Net shares
−30.78K
Net value
-$619.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2026 | S · Sale | −30.78K | $20.13 | $619.64K | 35.3% | 87.26K | 56.48K |
| Total | −30.78K | -$619.64K | ||||||
Derivative Transactions0
No derivative transactions reported